XOPIXOL LA 200mg|ml Injection 1ml

Frequently asked questions

• Onset of action

  The effect of this medicine can be observed within hours of oral administration and within 2-4 hours of intramuscular administration. However, the onset time is likely to vary based on the formulation. The depot injection shows its initial effect within 3 days of intramuscular administration.

• Duration of Effect

  The oral forms generally remain effective for 8 to 24 hours. The intramuscular injections are usually effective for 2 to 3 days while the depot injections are usually effective for 2 to 4 weeks.

• Safe with Alchohol?

  Consumption of alcohol is not recommended while receiving this medicine since it may increase the risk of dizziness, sedation, etc. Avoid performing activities that need high mental alertness like driving a vehicle or operating heavy machinery if you consume alcohol during treatment with this medicine.

• Is it habit forming?

  No habit-forming tendencies were reported.

• Usage in pregnancy?

  This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.

• Usage while breast-feeding?

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before beginning treatment with this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

• Allergy

  This medicine is not recommended for use in patients with a known allergy to XOPIXOL LA 200mg|ml Injection 1ml or any other inactive ingredients present in the formulation.

• Pheochromocytoma

  This medicine is not recommended for use in patients with pheochromocytoma (a rare cancer of the adrenal gland) due to the increased risk of worsening of the patient’s condition.

• Circulatory collapse

  This medicine is not recommended for use in patients with circulatory collapse due to the increased risk of worsening of the patient’s condition.

• Brain damage

  This medicine is not recommended for use in patients with brain damage due to the increased risk of worsening of the patient’s condition.

• Diminished consciousness

  This medicine is not recommended for use in patients with reduced or diminished consciousness that may be caused by various factors such as alcohol intoxication, opiate/barbiturate poisoning, etc. due to the increased risk of worsening of the patient’s condition.

• Pregnancy

  This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.

• Breast-feeding

  This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before beginning treatment with this medicine. Your doctor may advise you to discontinue breastfeeding or to discontinue the medicine based on your clinical condition.

• Other medicines

  XOPIXOL LA 200mg|ml Injection 1ml may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you inform the doctor about all your current medicines including any herbs and supplements before beginning treatment with this medicine.

• Use in the elderly

  This medicine should be used with caution and monitoring in elderly patients since the risk of serious or fatal adverse effects is significantly high. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.

• Use in children

  This medicine is not recommended for use in children below 18 years of age since the safety and efficacy of use are not clinically established.

• Heart diseases

  This medicine should be used with caution in patients with pre-existing heart conditions or patients who have had a heart attack in recent times. Frequent clinical monitoring of heart functions may be needed in such cases. Appropriate dose adjustments or replacement with a suitable alternative may be necessary in some cases.

• Liver diseases

  This medicine should be used with caution in patients with an impairment of normal liver function. Appropriate dose adjustments and frequent monitoring of liver function tests may be needed. Use is not recommended if the impairment is severe.

• Kidney diseases

  This medicine should be used with caution in patients with kidney diseases due to the increased risk of severe adverse effects. Regular monitoring of kidney function tests is necessary while receiving this medicine. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be required in some cases based on the clinical condition.

• Myasthenia Gravis

  This medicine should be used with extreme caution in patients having a degenerative disorder called myasthenia gravis. Use of this medicine should be reconsidered if the symptoms worsen after consumption. An alternative treatment option may be necessary in some cases based on the clinical condition.

• Low potassium and magnesium levels

  This medicine should be used with caution in patients with low levels of magnesium and potassium in the body. Treatment with this medicine should preferably resume only after the deficiency is corrected.

• Driving or Operating machinery

  Use of this medicine may cause symptoms such as blurred vision, dizziness, drowsiness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Oral form: Take this medicine with or without food. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesired side effects. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor. Injection: This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

• Usage does not depend on food timings
• To be taken as instructed by doctor
• May cause sleepiness

• practo.com - Zuclopenthixol [Internet]. Available from: https://www.practo.com/medicine-info/zuclopenthixol-2001-api [cited 28 september 2019]. 11 Jan 2019
• pubchem.ncbi.nlm.nih.gov - Zuclopenthixol [Internet]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Zuclopenthixol#section=Top [cited 28 september 2019]. 2019-09-21
• drugbank.ca - Zuclopenthixol [Internet]. Available from: https://www.drugbank.ca/drugs/DB01624 [cited 28 september 2019]. September 24, 2019